AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL
· Real-Time Price · USD
3.16
-0.04 (-1.25%)
At close: Jun 16, 2025, 3:59 PM
3.15
-0.35%
Pre-market: Jun 17, 2025, 04:57 AM EDT
AbCellera Biologics Revenue
AbCellera Biologics reported an annual revenue of $28.83M, reflecting a -24.17% growth. For the quarter ending March 31, 2025, AbCellera Biologics generated $4.24M in revenue.
Revenue (ttm)
$28.83M
Revenue Growth
-24.17%
Price / Sales Ratio
29.91
Revenue / Employee
$48.38K
Employees
596
Market Cap
943.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|